Crispr Therapeutics Ag (CRSP)

$55.14 +2.41 (4.57%)
Market Cap 4.87B
Revenue (ttm) 37.31M
Net Income (ttm) -366.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -981.64%
Debt to Equity Ratio 0.00
Volume 3,316,500
Avg Vol 2,879,750
Day's Range N/A - N/A
Shares Out 86.36M
Stochastic %K 33%
Beta 1.82
Analysts Strong Sell
Price Target $80.00

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 41 561 32 77
Address:
Baarerstrasse 14, Zug, Switzerland
SteveGomez
SteveGomez Jul. 16 at 8:57 PM
$CRSP The Sleeping Giant Is Waking Up. $100+ EOY 🧬
0 · Reply
Dr_Stoxx
Dr_Stoxx Jul. 16 at 8:45 PM
$CRSP inside day bar. 31% of the small float is held by short sellers.
1 · Reply
STONKEDDY
STONKEDDY Jul. 16 at 8:31 PM
$CRSP we have one more shot to take $65 level or they will short this into oblivion
0 · Reply
Joethenovice
Joethenovice Jul. 16 at 8:31 PM
$CRSP why the AH jump?
0 · Reply
SwarmOfDogs
SwarmOfDogs Jul. 16 at 8:18 PM
$CRSP
0 · Reply
TannerTDB
TannerTDB Jul. 16 at 7:30 PM
$CRSP New highs tomorrow.
0 · Reply
chrischackal
chrischackal Jul. 16 at 6:14 PM
$CRSP time for next leg yet?
0 · Reply
TannerTDB
TannerTDB Jul. 16 at 6:09 PM
$CRSP Shorts are getting anxious right about now. Rally continues.
0 · Reply
EMPIR3_37
EMPIR3_37 Jul. 16 at 5:58 PM
$CRSP While short interest is very high, share availability is increasing with borrow rates dropping. Long term bullish but still may see more SP pain here.
0 · Reply
LearnedPatience
LearnedPatience Jul. 16 at 5:06 PM
$SMCI $TSLA $CRSP
0 · Reply
Latest News on CRSP
The Big 3: ASML, GOOGL, CRSP

Jul 15, 2025, 12:01 PM EDT - 1 day ago

The Big 3: ASML, GOOGL, CRSP

ASML GOOG GOOGL

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

Jul 14, 2025, 8:00 AM EDT - 2 days ago

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Jun 26, 2025, 7:00 AM EDT - 20 days ago

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

The Big 3: CRSP, OKLO, GME

Jun 23, 2025, 12:01 PM EDT - 23 days ago

The Big 3: CRSP, OKLO, GME

OKLO GME

Crispr Therapeutics: Betting On A One-Shot Future

Jun 13, 2025, 6:27 PM EDT - 4 weeks ago

Crispr Therapeutics: Betting On A One-Shot Future

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Jun 9, 2025, 5:50 PM EDT - 5 weeks ago

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

Jun 3, 2025, 4:07 PM EDT - 6 weeks ago

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

May 29, 2025, 8:30 AM EDT - 6 weeks ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

May 9, 2025, 7:14 AM EDT - 2 months ago

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

May 8, 2025, 8:36 AM EDT - 2 months ago

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

May 7, 2025, 4:03 PM EDT - 2 months ago

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

May 7, 2025, 2:17 PM EDT - 2 months ago

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

May 7, 2025, 8:39 AM EDT - 2 months ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

May 6, 2025, 4:01 PM EDT - 2 months ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

May 5, 2025, 4:44 AM EDT - 2 months ago

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

NTLA

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

Apr 8, 2025, 3:29 PM EDT - 3 months ago

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 8:00 AM EDT - 3 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Mar 26, 2025, 4:01 PM EDT - 4 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

CRISPR Therapeutics Set To Reach Previous Heights

Mar 25, 2025, 11:03 AM EDT - 4 months ago

CRISPR Therapeutics Set To Reach Previous Heights

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 3:28 PM EST - 4 months ago

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 8:00 AM EST - 5 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

Feb 13, 2025, 11:06 AM EST - 5 months ago

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 11, 2025, 4:01 PM EST - 5 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Feb 5, 2025, 4:16 PM EST - 5 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Feb 5, 2025, 3:48 PM EST - 5 months ago

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

Jan 15, 2025, 7:20 PM EST - 6 months ago

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 14, 2025, 7:39 PM EST - 6 months ago

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 8:30 AM EST - 6 months ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

Dec 29, 2024, 12:56 PM EST - 7 months ago

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

Dec 9, 2024, 12:00 PM EST - 7 months ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

Nov 20, 2024, 9:28 PM EST - 8 months ago

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Nov 15, 2024, 11:37 AM EST - 8 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Nov 14, 2024, 8:30 AM EST - 8 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

Nov 11, 2024, 12:54 PM EST - 8 months ago

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 9:01 AM EST - 9 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Crispr Therapeutics: Poised For A Major Turnaround

Oct 28, 2024, 6:36 AM EDT - 9 months ago

Crispr Therapeutics: Poised For A Major Turnaround

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

Oct 6, 2024, 2:00 PM EDT - 10 months ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY EDIT EXAS NTLA

Crispr Therapeutics: Prepare To Be Bored

Sep 18, 2024, 9:11 AM EDT - 10 months ago

Crispr Therapeutics: Prepare To Be Bored

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Aug 14, 2024, 6:08 AM EDT - 1 year ago

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

Aug 7, 2024, 10:41 AM EDT - 1 year ago

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 5, 2024, 4:01 PM EDT - 1 year ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Crispr Therapeutics: Beaten Down But Not Broken

Jul 7, 2024, 8:30 AM EDT - 1 year ago

Crispr Therapeutics: Beaten Down But Not Broken

CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript

Jun 11, 2024, 12:32 PM EDT - 1 year ago

CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript

Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)

Jun 10, 2024, 10:27 AM EDT - 1 year ago

Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)

The 'Undercovered' Dozen From June 1-6

Jun 7, 2024, 6:26 PM EDT - 1 year ago

The 'Undercovered' Dozen From June 1-6

ALNY CLOV ENVX GAM HAL LPA PEO

CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)

Jun 6, 2024, 12:40 AM EDT - 1 year ago

CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)

Final Trade: UAL, NKE, SLV & CRSP

May 24, 2024, 7:40 PM EDT - 1 year ago

Final Trade: UAL, NKE, SLV & CRSP

SLV NKE UAL

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

May 23, 2024, 8:00 AM EDT - 1 year ago

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)

May 15, 2024, 4:12 PM EDT - 1 year ago

CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

May 9, 2024, 8:30 AM EDT - 1 year ago

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

SteveGomez
SteveGomez Jul. 16 at 8:57 PM
$CRSP The Sleeping Giant Is Waking Up. $100+ EOY 🧬
0 · Reply
Dr_Stoxx
Dr_Stoxx Jul. 16 at 8:45 PM
$CRSP inside day bar. 31% of the small float is held by short sellers.
1 · Reply
STONKEDDY
STONKEDDY Jul. 16 at 8:31 PM
$CRSP we have one more shot to take $65 level or they will short this into oblivion
0 · Reply
Joethenovice
Joethenovice Jul. 16 at 8:31 PM
$CRSP why the AH jump?
0 · Reply
SwarmOfDogs
SwarmOfDogs Jul. 16 at 8:18 PM
$CRSP
0 · Reply
TannerTDB
TannerTDB Jul. 16 at 7:30 PM
$CRSP New highs tomorrow.
0 · Reply
chrischackal
chrischackal Jul. 16 at 6:14 PM
$CRSP time for next leg yet?
0 · Reply
TannerTDB
TannerTDB Jul. 16 at 6:09 PM
$CRSP Shorts are getting anxious right about now. Rally continues.
0 · Reply
EMPIR3_37
EMPIR3_37 Jul. 16 at 5:58 PM
$CRSP While short interest is very high, share availability is increasing with borrow rates dropping. Long term bullish but still may see more SP pain here.
0 · Reply
LearnedPatience
LearnedPatience Jul. 16 at 5:06 PM
$SMCI $TSLA $CRSP
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Jul. 16 at 3:40 PM
$CRSP this was a complete sell off and also trapped alot of newbies. These institutions are not holding anything for more than a 8% gain anymore. Too much uncertainty.
2 · Reply
Ca777111
Ca777111 Jul. 16 at 2:53 PM
$CRSP curative small/mid size American biotech that reduce long term healthcare costs will benefit from the new admin. Imo gene editing is a uniquely positioned sub industry that will benefit extensively from RFKs future policy. Prasad or no Prasad.
0 · Reply
gargoyl
gargoyl Jul. 16 at 2:37 PM
$BLRX 👀 Examples of coiled; 1- BLRX @ 4.50 2- The snake 🐍 below 3- thunder following ⚡️ 4- A fuse making its way to a 💣 Target 🎯 $12 this year $8 imminently $24 not out question $70 w/ with a $250M market cap following a PDAC catalyst.. not for the the faint hearted .. $CRSP $VSTM $JOBY 🐎 Long the 🦋
0 · Reply
STONKEDDY
STONKEDDY Jul. 16 at 1:40 PM
$CRSP here’s our chance to take these levels back. If not, we will head back to $43.
1 · Reply
Dios890
Dios890 Jul. 16 at 1:38 PM
$CRSP just waiting...waiting....waiting...
0 · Reply
Deejay47
Deejay47 Jul. 16 at 12:47 PM
$NTLA I see NTLA slowly creeping towards $20 mark and after that interest rate cuts/ bullish clinical or pipeline news/ positive political sentiment towards the sector could easily begin doubling the stock price. I believe both $NTLA and $CRSP are remarkable companies and current valuations (looking at book value) are a joke imo. At this point invested only in intellia but rooting for crsp at the same time :)
1 · Reply
BitcoinMillionaire888
BitcoinMillionaire888 Jul. 16 at 6:23 AM
$CRSP i am loading more today. Company is thr best AI gene therapy out there with real revenue for already approved sickle cell; huge volume of parents, $BILLIONS in cash, amazing world leading pharma as leading investors, Cathie Wood buying millions each month; amazing pipeline for cancer, cardio, auto-immune, diebetes and others showing great results. $100 is fair value, I will keep buying until then. Buyout very possible on weak share price! watch out shorts 😁
1 · Reply
STONKEDDY
STONKEDDY Jul. 16 at 1:57 AM
$CRSP definitely following the breakout, then short pattern. Sigh
1 · Reply
SwarmOfDogs
SwarmOfDogs Jul. 16 at 1:53 AM
$CRSP
0 · Reply
handmedown1
handmedown1 Jul. 15 at 11:26 PM
$CRSP
0 · Reply
MF__DOOM
MF__DOOM Jul. 15 at 9:27 PM
$SPY $QQQ $CRSP $XBI see you all tomorrow
0 · Reply
BitcoinMillionaire888
BitcoinMillionaire888 Jul. 15 at 7:40 PM
$CRSP i had used some recent profits here to buy a load of $MP on Friday now selling all the MP and putting ALL back in here, still fully expect $75 soon and a real large pain for shorts who are playing with fire. 30% chance of unsolicted offer in next few months at these levels. Good luck!
2 · Reply